Organism 66293 - Ganoderma lucidum (GANODERMATACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon3606
FamilyGANODERMATACEAE
GenusGANODERMA
SpeciesLUCIDUM
Species authority(CURTIS:FR.) KARST.
Subspecies
Subspecies authority
Comment
CitationEL-MEKKAWY,S: MESELHY,MR: NAKAMURA,N: TEZUKA,Y: HATTORI,M: KAKIUCHI,N: SHIMOTOHNO,K: KAWAHATA,T: OTAKE,T:. (1998). ANTI-HIV-1 AND ANTI-HIV-1-PROTEASE SUBSTANCES FROM GANODERMA LUCIDUM.. 49(6)
Geographical areaEASTERN ASIA
CountryJAPAN

Experiments

Filters
Worktypes (13)
39
14
13
12
11
2
1
1
1
1
1
1
1
No match
Pharmacology (4)
14
14
13
13
No match
Compounds (14)
4
4
4
4
4
4
4
4
4
4
4
4
4
2
No match
54 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
228042
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
228043
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228044
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
228045
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
228046
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
228047
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
228048
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
228049
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
228050
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
228051
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
228052
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
228053
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
228054
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
228055
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
228056
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
228057
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
228058
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
228059
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
228060
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228061
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228062
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228063
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228064
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
228065
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
228066
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
228067
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
228068
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
228069
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
228070
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
228071
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
228072
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
228073
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
228074
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
228075
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
228076
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
228077
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
228078
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
228079
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
228080
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
228081
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
228082
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
228083
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
228084
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
228085
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
228086
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
228087
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
228088
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
228089
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
228090
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
228091
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
228092
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
228093
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
228094
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
228095
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
Show SPARQL Queries (1)